Tang Capital Management’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-510,329
| Closed | -$487K | – | 215 |
|
|
2025
Q1 | $487K | Buy |
510,329
+340,329
| +200% | +$325K | 0.03% | 184 |
|
|
2024
Q4 | $308K | Buy |
+170,000
| New | +$308K | 0.02% | 178 |
|
|
2023
Q2 | – | Sell |
-53,200
| Closed | -$223K | – | 109 |
|
|
2023
Q1 | $223K | Buy |
53,200
+29,075
| +121% | +$122K | 0.03% | 96 |
|
|
2022
Q4 | $103K | Buy |
+24,125
| New | +$103K | 0.01% | 86 |
|
|
2022
Q3 | – | Sell |
-1,200,000
| Closed | -$1.32M | – | 98 |
|
|
2022
Q2 | $1.32M | Hold |
1,200,000
| – | – | 0.2% | 57 |
|
|
2022
Q1 | $2.95M | Hold |
1,200,000
| – | – | 0.59% | 38 |
|
|
2021
Q4 | $3.47M | Hold |
1,200,000
| – | – | 0.7% | 24 |
|
|
2021
Q3 | $4.88M | Hold |
1,200,000
| – | – | 1.01% | 16 |
|
|
2021
Q2 | $5.83M | Buy |
+1,200,000
| New | +$5.83M | 1.16% | 11 |
|